New AI institute to focus on veterans’ health

The U.S. Department of Veterans Affairs (VA) has launched the National Artificial Intelligence Institute (NAII) to develop AI research for improving the health and well-being of U.S. veterans.   

The agency is “an ideal environment for advancing AI technology,” according to a prepared statement. AI research currently being spearheaded by the VA includes work on mental health, improving day-to-day patient treatments and decreasing wait times.

“VA’s artificial intelligence institute will usher in new capabilities and opportunities that will improve health outcomes for our nation’s heroes,” VA Secretary Robert Wilkie said in the statement.

The VA’s Office of Research and Development and Secretary’s Center for Strategic Partnerships worked together on this new initiative. The announcement was designed to coincide with National Veterans and Military Families Month.

More information is available on the VA’s website.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.